Founded in 2014 by two University of Texas at San Antonio alumni, Vitanova Biomedical Incorporated (VNB) is a San Antonio, Texas-based early-stage biotechnology company focusing on the development and implementation of proprietary intellectual property that has proven successful in killing cancer in vitro (in a petri dish).

Currently, we are conducting pre-clinical trials utilizing our proprietary light-activated acidosis therapy to treat and kill multiple types of aggressive cancer cells, and have secured our CRO (Clinical Research Organization) partner (Cancer Insight, San Antonio, TX) to conduct our Phase I through Phase III clinical testing. Our Executive Leadership Team includes highly experienced and qualified leaders that are well-seasoned within the healthcare sector.

Click “play” to view a recent interview with Dr. Gdovin describing Vitanova Biomedical and light-activated intracellular acidosis technology┬á